ArticleFrontiers in immunology2023

Bruton's tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome.

Sarah Kröller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.